Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

The RNA Targeting Small Molecule Drug Discovery Market is poised for growth, driven by demand for treatments targeting cancer ...

Insilico Medicine said results of a clinical trial in China showed positive results in treating idiopathic pulmonary fibrosis ...

Phil Lambert, Ph.D., chief scientific officer of Satellos Bioscience Inc., explains the mechanism of action of the company's experimental Duchenne muscular dystrophy drug, SAT-3247, and the thinking ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Satellos Bioscience's experimental small-molecule drug for Duchenne muscular dystrophy is showing positive results as a stand-alone treatment, but Phil Lambert, Ph.D., the company's chief scientific ...

President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of ...

Transposon said its oral small molecule TPN-101 has been selected for testing as part of the HEALEY ALS platform trial.

According to a McKinsey analysis, women spend 25% more time than men in poor health — and investments addressing the women’s ...

The investigational drug demonstrated robust STAT6 degradation in blood and skin that was well tolerated and safe in healthy ...